Barcelona, Spain

Francisco Pubill Coy

This inventor holds 10 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: Lacer, S.a., Lacer. Active years: 1995-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francisco Pubill Coy. Retrieved from https://idiyas.com/inventor/francisco-pubill-coy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 20.0

 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Cabrils, ES (2011 - 2012)
  • Barcelona, ES (1995 - 2013)

Company Filing History:


Years Active: 1995-2013

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Francisco Pubill Coy: Innovator in Pharmaceutical Chemistry

Introduction

Francisco Pubill Coy is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work focuses on the development of novel compounds with potential therapeutic applications.

Latest Patents

Among his latest patents, one notable invention is related to disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars. This invention discloses new derivatives of dianhydrohexite mononitrate, which include tautomers, pharmaceutically acceptable salts, prodrugs, and solvates. Additionally, he has developed pharmaceutical compositions comprising these compounds and their uses. Another significant patent involves isosorbide nitrates, which pertains to new 3-substituted 6-nitrooxy-hexahydrofuro[3,2-b]furane derivatives. These derivatives exhibit superior pharmacological activity in models of thrombosis and coronary ischemia.

Career Highlights

Throughout his career, Francisco has worked with prominent companies in the pharmaceutical industry, including Lacer, S.A. and Lacer. His expertise in the field has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

Francisco has collaborated with esteemed colleagues such as Jose Repolles Moliner and Lydia Cabeza Llorente. These partnerships have further enriched his research and development efforts.

Conclusion

Francisco Pubill Coy stands out as a significant figure in pharmaceutical innovation, with a strong portfolio of patents that reflect his dedication to advancing medical science. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…